Astera Labs Q2 EPS Forecast Raised by Northland Securities

Astera Labs, Inc. (NASDAQ:ALAB) – Northland Securities raised their Q2 2026 EPS estimates for Astera Labs in a report released on Wednesday, May 6th. Northland Securities analyst G. Richard now forecasts that the company will post earnings of $0.42 per share for the quarter, up from their previous forecast of $0.33. The consensus estimate for Astera Labs’ current full-year earnings is $1.48 per share. Northland Securities also issued estimates for Astera Labs’ Q3 2026 earnings at $0.47 EPS, Q4 2026 earnings at $0.56 EPS, FY2026 earnings at $1.82 EPS, Q1 2027 earnings at $0.54 EPS, Q2 2027 earnings at $0.54 EPS, Q3 2027 earnings at $0.58 EPS, Q4 2027 earnings at $0.61 EPS and FY2027 earnings at $2.26 EPS.

Several other equities research analysts also recently commented on the stock. Citigroup boosted their target price on shares of Astera Labs from $200.00 to $245.00 and gave the stock a “buy” rating in a research report on Wednesday, May 6th. Needham & Company LLC upped their price objective on shares of Astera Labs from $220.00 to $260.00 and gave the stock a “buy” rating in a research report on Wednesday, May 6th. Morgan Stanley upped their price objective on shares of Astera Labs from $210.00 to $240.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 6th. Barclays upped their price objective on shares of Astera Labs from $165.00 to $200.00 and gave the stock an “equal weight” rating in a research report on Thursday, May 7th. Finally, JPMorgan Chase & Co. upped their price objective on shares of Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 6th. Fifteen analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $229.65.

Astera Labs Price Performance

NASDAQ:ALAB opened at $224.09 on Thursday. The firm has a 50-day moving average of $150.64 and a 200-day moving average of $155.42. The company has a market cap of $38.41 billion, a PE ratio of 151.41, a PEG ratio of 3.37 and a beta of 3.35. Astera Labs has a one year low of $84.78 and a one year high of $262.90.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping the consensus estimate of $0.54 by $0.07. The company had revenue of $308.36 million during the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The firm’s revenue for the quarter was up 93.5% on a year-over-year basis. During the same period in the previous year, the firm posted $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ALAB. Assetmark Inc. boosted its stake in Astera Labs by 374.1% in the third quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after acquiring an additional 101 shares during the last quarter. Reflection Asset Management purchased a new stake in shares of Astera Labs during the 4th quarter valued at approximately $25,000. Smartleaf Asset Management LLC lifted its stake in shares of Astera Labs by 422.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after buying an additional 152 shares in the last quarter. Hilltop National Bank lifted its stake in shares of Astera Labs by 100.0% during the 4th quarter. Hilltop National Bank now owns 200 shares of the company’s stock valued at $33,000 after buying an additional 100 shares in the last quarter. Finally, Aventura Private Wealth LLC purchased a new stake in shares of Astera Labs during the 4th quarter valued at approximately $33,000. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Astera Labs

In other Astera Labs news, CFO Michael Truett Tate sold 12,001 shares of the business’s stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total value of $1,485,843.81. Following the transaction, the chief financial officer directly owned 192,083 shares in the company, valued at $23,781,796.23. The trade was a 5.88% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Sanjay Gajendra sold 230,639 shares of the business’s stock in a transaction dated Thursday, May 7th. The shares were sold at an average price of $198.22, for a total transaction of $45,717,262.58. Following the completion of the transaction, the chief operating officer owned 664,361 shares in the company, valued at approximately $131,689,637.42. The trade was a 25.77% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 1,497,338 shares of company stock valued at $236,827,957 in the last three months. Insiders own 12.50% of the company’s stock.

Key Headlines Impacting Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Northland Securities raised its earnings outlook for Astera Labs (ALAB) across multiple periods, including Q2 2026, Q3 2026, Q4 2026, Q1 2027, Q2 2027, Q3 2027, Q4 2027, FY2026, and FY2027. The higher estimates suggest analysts see stronger growth and profitability ahead, which can support the stock. Article Title
• Neutral Sentiment: Astera Labs announced participation in several second-quarter 2026 financial conferences. While this keeps the company visible to investors, the announcement itself does not change fundamentals. Article Title
• Neutral Sentiment: A Yahoo Finance article said shareholders can be confident that Astera Labs’ earnings are high quality, which may reinforce investor confidence but is not a major new catalyst by itself. Article Title
• Negative Sentiment: Another Yahoo Finance report noted that Artisan Mid Cap Fund reduced its holdings in Astera Labs, a mild cautionary signal that some investors are trimming exposure. Article Title

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.